Skip to main content
Key Specialties
Anesthesiology Cardiology Dermatology Diabetology Endocrinology Gastroenterology General Medicine Geriatrics Hematology Infectious Diseases Internal Medicine Nephrology Neurology Obstetrics and Gynecology Oncology Ophthalmology Pediatrics Psychiatry Radiology Respiratory Medicine Rheumatology Surgery Urology
Congress Coverage
ASH 2024 Annual Meeting 2024 ESMO Congress 2024 ERS Congress 2024 EASD Congress 2024 ESC Congress 2024 EAN Congress 2024 ASCO Annual Meeting 2024 ACC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on adolescent vaping

Growing numbers of young people are using e-cigarettes, despite warnings of respiratory effects and addiction. How can doctors tackle the epidemic, and what health effects should you prepare to manage in your clinics?

Watch the on-demand webinar
ADVANCED SEARCH
Log in
Top
Breast Cancer Research and Treatment
Published in:

Open Access 05-05-2024 | Breast Cancer | Correction

Correction: Performance of a novel spectroscopy-based tool for adjuvant therapy decision-making in hormone receptor-positive breast cancer: a validation study

Authors: R Charles Coombes, Christina Angelou, Zamzam Al-Khalili, William Hart, Darius Francescatti, Nicholas Wright, Ian Ellis, Andrew Green, Emad Rakha, Sami Shousha, Hemmel Amrania, Chris C. Phillips, Carlo Palmieri

Published in: Breast Cancer Research and Treatment | Issue 1/2024

Login to get access

Excerpt

Correction: Breast Cancer Research and Treatment …
Metadata
Title
Correction: Performance of a novel spectroscopy-based tool for adjuvant therapy decision-making in hormone receptor-positive breast cancer: a validation study
Authors
R Charles Coombes
Christina Angelou
Zamzam Al-Khalili
William Hart
Darius Francescatti
Nicholas Wright
Ian Ellis
Andrew Green
Emad Rakha
Sami Shousha
Hemmel Amrania
Chris C. Phillips
Carlo Palmieri
Publication date
05-05-2024
Publisher
Springer US
Published in
Breast Cancer Research and Treatment / Issue 1/2024
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-024-07276-z

Other articles of this Issue 1/2024

BRCA1/2 mutation carriers vs the general breast cancer population (N = 799,986): 21-gene assay-based molecular characterization

Recreational physical activity and breast cancer risk by menopausal status and tumor hormone receptor status: results from the Nurses’ Health Studies

Expression of Cathepsin D in early-stage breast cancer and its prognostic and predictive value

Lifestyle interventions with dietary strategies after breast cancer diagnosis: a systematic review

Is postmastectomy radiotherapy necessary for breast cancer patients with clinically node-positive downstaging to ypN0 after neoadjuvant chemotherapy?

Clinical and molecular predictors of very late recurrence in oestrogen receptor-positive breast cancer patients

ASH 2024 Annual Meeting Coverage

inMIND supports tafasitamab addition in follicular lymphoma

Combining tafasitamab with lenalidomide and rituximab significantly improves progression-free survival for patients with relapsed or refractory follicular lymphoma.

Featuring the official presentation video

Read more

Transplantation can be omitted for certain MCL patients

Add-on blinatumomab improves DFS in children with ALL

Promising response to loncastuximab tesirine in lymphoma

» View more highlights on the ASH 2024 hub page

SPONSORED

Recent advances in the use of CAR T-cell therapies in relapsed/refractory diffuse large B-cell lymphoma and follicular lymphoma

In this webinar, Professor Martin Dreyling and an esteemed international panel of CAR T-cell therapy experts discuss the latest data on the safety, efficacy, and clinical impact of CAR T-cell therapies in the treatment of r/r DLBCL and r/r FL.

Please note, this webinar is not intended for healthcare professionals based in the US and UK.

Sponsored by:
  • Novartis Pharma AG
Chaired by: Prof. Martin Dreyling
Developed by: Springer Healthcare
Watch now
Image Credits